NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 279 filers reported holding NEOGENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,386 | -24.4% | 193,950 | -1.3% | 2.36% | -14.1% |
| Q2 2023 | $3,158 | -7.9% | 196,500 | -0.3% | 2.75% | -14.9% |
| Q1 2023 | $3,430 | +87.7% | 197,000 | -0.4% | 3.23% | +67.7% |
| Q4 2022 | $1,827 | -99.9% | 197,700 | +1.1% | 1.93% | +2.4% |
| Q3 2022 | $1,684,000 | +2.0% | 195,550 | -3.5% | 1.88% | +10.2% |
| Q2 2022 | $1,651,000 | -10.9% | 202,550 | +32.8% | 1.71% | +12.5% |
| Q1 2022 | $1,853,000 | -65.1% | 152,550 | -1.9% | 1.52% | -57.6% |
| Q4 2021 | $5,307,000 | -30.3% | 155,550 | -1.4% | 3.58% | -23.9% |
| Q3 2021 | $7,610,000 | +6.4% | 157,750 | -0.3% | 4.71% | +16.1% |
| Q2 2021 | $7,150,000 | -7.8% | 158,300 | -1.6% | 4.06% | -9.5% |
| Q1 2021 | $7,755,000 | -20.5% | 160,800 | -11.3% | 4.48% | -29.7% |
| Q4 2020 | $9,759,000 | +32.6% | 181,250 | -9.2% | 6.38% | -5.6% |
| Q3 2020 | $7,360,000 | +13.5% | 199,525 | -15.0% | 6.76% | -13.7% |
| Q1 2020 | $6,484,000 | -12.2% | 234,850 | -7.0% | 7.83% | +18.3% |
| Q4 2019 | $7,386,000 | +47.3% | 252,500 | -3.7% | 6.62% | +53.2% |
| Q3 2019 | $5,015,000 | -18.3% | 262,300 | -6.2% | 4.32% | +0.5% |
| Q2 2019 | $6,137,000 | +13.3% | 279,700 | +5.7% | 4.30% | +20.6% |
| Q1 2019 | $5,415,000 | +52.5% | 264,650 | -6.0% | 3.56% | +29.5% |
| Q4 2018 | $3,550,000 | -18.5% | 281,500 | -0.8% | 2.75% | +5.2% |
| Q3 2018 | $4,358,000 | +14.7% | 283,900 | -2.0% | 2.62% | -3.9% |
| Q2 2018 | $3,799,000 | +59.0% | 289,800 | -1.0% | 2.72% | +26.4% |
| Q1 2018 | $2,390,000 | -9.4% | 292,850 | -1.7% | 2.15% | -15.2% |
| Q4 2017 | $2,639,000 | -23.1% | 297,850 | -3.4% | 2.54% | -29.4% |
| Q3 2017 | $3,431,000 | +24.0% | 308,300 | -0.2% | 3.60% | +17.1% |
| Q2 2017 | $2,767,000 | -32.6% | 308,800 | -40.6% | 3.07% | -27.5% |
| Q1 2017 | $4,105,000 | -9.7% | 520,275 | -1.9% | 4.24% | -15.0% |
| Q4 2016 | $4,544,000 | -15.7% | 530,175 | -19.2% | 4.98% | -7.6% |
| Q3 2016 | $5,391,000 | -0.4% | 655,800 | -2.6% | 5.39% | -13.1% |
| Q2 2016 | $5,411,000 | +15.1% | 673,032 | -3.5% | 6.20% | +5.4% |
| Q1 2016 | $4,701,000 | -15.2% | 697,482 | -1.0% | 5.88% | -1.1% |
| Q4 2015 | $5,544,000 | +21.8% | 704,432 | -11.3% | 5.95% | +17.5% |
| Q3 2015 | $4,550,000 | +5.5% | 794,012 | -0.4% | 5.06% | +33.7% |
| Q2 2015 | $4,311,000 | +14.1% | 796,930 | -1.5% | 3.79% | +19.5% |
| Q1 2015 | $3,779,000 | +11.0% | 809,180 | -0.9% | 3.17% | +8.4% |
| Q4 2014 | $3,406,000 | -19.8% | 816,680 | +0.2% | 2.92% | -18.6% |
| Q3 2014 | $4,246,000 | +61.9% | 814,980 | +3.2% | 3.59% | +94.5% |
| Q2 2014 | $2,623,000 | -4.3% | 789,980 | 0.0% | 1.84% | -4.1% |
| Q1 2014 | $2,741,000 | -0.2% | 789,980 | +4.1% | 1.92% | +3.8% |
| Q4 2013 | $2,746,000 | +61.2% | 758,680 | +33.7% | 1.85% | +51.3% |
| Q3 2013 | $1,703,000 | +14.6% | 567,607 | +52.0% | 1.22% | +3.8% |
| Q2 2013 | $1,486,000 | – | 373,380 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,046,639 | $12,874 | 8.15% |
| Greenhouse Funds LLLP | 3,981,003 | $48,966,337 | 3.62% |
| First Light Asset Management, LLC | 3,028,913 | $37,255,630 | 3.54% |
| PERKINS CAPITAL MANAGEMENT INC | 193,950 | $2,386 | 2.36% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,557,895 | $19,162,109 | 1.16% |
| EMERALD ADVISERS, LLC | 1,927,074 | $23,703,005 | 1.15% |
| Bullseye Asset Management LLC | 163,792 | $2,015 | 1.12% |
| FORMULA GROWTH LTD | 208,885 | $2,569,286 | 0.88% |
| OAK FAMILY ADVISORS, LLC | 96,737 | $1,189,865 | 0.56% |
| Parkman Healthcare Partners LLC | 245,812 | $3,023,488 | 0.55% |